文献
J-GLOBAL ID:202002227831983439
整理番号:20A2059679
COVID-19に対する熱安定性mRNAワクチン【JST・京大機械翻訳】
A Thermostable mRNA Vaccine against COVID-19
著者 (32件):
Zhang Na-Na
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Zhang Na-Na
(School of Medicine, Tsinghua University, Beijing 100084, China)
,
Li Xiao-Feng
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Deng Yong-Qiang
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Zhao Hui
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Huang Yi-Jiao
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Yang Guan
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China)
,
Huang Wei-Jin
(Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China)
,
Gao Peng
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Zhou Chao
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Zhang Rong-Rong
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Guo Yan
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Sun Shi-Hui
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Fan Hang
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Zu Shu-Long
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Chen Qi
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
He Qi
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China)
,
Cao Tian-Shu
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Huang Xing-Yao
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Qiu Hong-Ying
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Nie Jian-Hui
(Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China)
,
Jiang Yuhang
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Yan Hua-Yuan
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Ye Qing
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Zhong Xia
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Xue Xia-Lin
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Zha Zhen-Yu
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Zhou Dongsheng
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
,
Yang Xiao
(State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China)
,
Wang You-Chun
(Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing 102629, China)
,
Ying Bo
(Suzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China)
,
Qin Cheng-Feng
(State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China)
資料名:
Cell (Cambridge, Mass.)
(Cell (Cambridge, Mass.))
巻:
182
号:
5
ページ:
1271-1283.e16
発行年:
2020年
JST資料番号:
A0707B
ISSN:
0092-8674
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)